Valuation check: APTA.ST's profit margin is -1706.14%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Aptahem AB (publ) (APTA.ST) currently reports a profit margin of -1706.14% as of June 2026. That compares with -180.14% in the prior-year period — down 847.1% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Aptahem AB (publ)'s profit margin history and peer comparisons.
Aptahem AB (publ)'s profit margin decreased from -180.14% to -1706.14% — a 847.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Aptahem AB (publ)'s profit margin of -1706.14% is lower than the Healthcare sector average of 17.63%. That is roughly 9778.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Aptahem AB (publ)'s current -1706.14% should be judged against Healthcare norms (sector average: 17.63%) and against APTA.ST's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -1706.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Aptahem AB (publ), and consider following APTA.ST for alerts when major investors trade the stock.